InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: cicle1 post# 149249

Sunday, 03/29/2015 10:06:37 AM

Sunday, March 29, 2015 10:06:37 AM

Post# of 399482
And I've heard the same line of reasoning since .068 and there wasn't even a quarter of what has transpired since then - many of which I have already explicated- if I waited for all the "promises" to be fulfilled - I'd be one of those new investors buying ELTP at $1 or even $2.

1) The PPS has climbed from .068 to .238.

2) Hired an executive VP of Operations and a VP of Quality Operations and Regulatory Affiars. The first used to work at Actavis and the second at Alpharma.

3) Launched Generic Naltrexone and Isradipine.

4) Successful BE results of Eli 200 and 201 AND positive HAL data for Eli 200.

5) Garners 2 more ADT patents in Canada.

6) Garners $40 million in Funding for ART trials from LPC.

7) Adds 3 top executive positions including the previous IP lawyer from Alpharma and Sanofi Aventis.

8) Receives FDA guidance for Elite's Phase III efficacy trail for Eli 200 and has currently completed its Phase 3 withdrawal study.

9) Been approved for their Micro Tablet Patent which Elie will combine with its patented abuse resistat technology.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News